Pliant Therapeutics, Inc.
PLRX
$1.48
$0.010.68%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.98% | -39.23% | -35.59% | -25.05% | -17.25% |
| Total Depreciation and Amortization | -1.29% | 18.75% | 30.40% | 13.50% | 1.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.42% | 47.59% | 19.52% | 14.98% | 50.68% |
| Change in Net Operating Assets | -1,443.35% | 683.74% | -127.56% | 251.31% | 109.30% |
| Cash from Operations | -89.87% | 10.91% | -82.95% | 0.02% | 19.65% |
| Capital Expenditure | -242.62% | -853.19% | -107.46% | -815.34% | 63.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.01% | -16.93% | 153.42% | 135.07% | 58.42% |
| Cash from Investing | 22.59% | -19.07% | 146.57% | 134.18% | 59.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -56.47% | -29.84% | 104.79% | -99.31% | 321.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -105.68% |
| Cash from Financing | -53.42% | -22.32% | 324.84% | -92.03% | -22.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -219.75% | -128.23% | 28.72% | -25.83% | 164.37% |